NCT06879873View on ClinicalTrials.gov

MRD-Guided Surveillance in Operable Colon Adenocarcinoma (I-III)(SURVEILLANCE-I)

Not yet recruitingOBSERVATIONAL

Enrollment

390

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2029

Conditions

Colorectal Cancer (CRC)

All Listed Sponsors

lead

Fudan University

OTHER